Mototsugu Muramaki
Papers
8
Total Citations
151
H-Index
7
About
Dr. Mototsugu Muramaki is a leading figure in urologic oncology, renowned for pioneering the adoption and refinement of robotic surgery in Japan. His research centers on optimizing surgical outcomes for prostate and kidney cancers, with a major focus on robot-assisted partial nephrectomy (RAPN) and radical prostatectomy (RARP). Dr. Muramaki’s key contributions include landmark comparative studies on surgical approaches—such as his highly cited 2013 work comparing transperitoneal and retroperitoneal RAPN (61 citations)—and the development of nephron-sparing techniques. He demonstrated the significant impact of the R.E.N.A.L. nephrometry score on postoperative renal function and championed selective renal arterial clamping to preserve kidney function. In prostate cancer, he advanced nerve-sparing techniques, using 3-Tesla MRI to guide neurovascular bundle preservation, and compared postoperative infection rates between robotic and open prostatectomy. His work has been instrumental in establishing robotic surgery as a safe, effective standard in Japan, with cumulative citations exceeding 150. Dr. Muramaki has also innovated surgical ergonomics, evaluating 3D vision systems for surgical assistants, further solidifying his reputation as a comprehensive innovator in minimally invasive urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8